Last reviewed · How we verify

Attenuated Hepatitis A Vaccine, H2 Strain — Competitive Intelligence Brief

Attenuated Hepatitis A Vaccine, H2 Strain (Attenuated Hepatitis A Vaccine, H2 Strain) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine. Area: Immunology.

marketed Live attenuated vaccine Hepatitis A virus Immunology Biologic Live · refreshed every 30 min

Target snapshot

Attenuated Hepatitis A Vaccine, H2 Strain (Attenuated Hepatitis A Vaccine, H2 Strain) — Jiangsu Province Centers for Disease Control and Prevention. The Attenuated Hepatitis A Vaccine, H2 Strain, works by introducing a live, weakened form of the hepatitis A virus to stimulate an immune response.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Attenuated Hepatitis A Vaccine, H2 Strain TARGET Attenuated Hepatitis A Vaccine, H2 Strain Jiangsu Province Centers for Disease Control and Prevention marketed Live attenuated vaccine Hepatitis A virus
Vaqta Injectable Product Vaqta Injectable Product National Taiwan University Hospital marketed Inactivated viral vaccine Hepatitis A virus surface antigen
Havrix 720 Junior Havrix 720 Junior Chiang Mai University marketed Inactivated viral vaccine Hepatitis A virus surface antigen
HepA-I HepA-I Sinovac Biotech Co., Ltd marketed Inactivated viral vaccine Hepatitis A virus (HAV)
Havrix+Healive Havrix+Healive Sinovac Biotech Co., Ltd marketed Combination inactivated viral vaccine Hepatitis A virus antigen; Hepatitis B surface antigen (HBsAg)
Comparator: VAQTA™ Comparator: VAQTA™ Merck Sharp & Dohme LLC marketed Inactivated viral vaccine Hepatitis A virus antigen
HAVpur Junior HAVpur Junior Crucell Holland BV marketed Inactivated viral vaccine Hepatitis A virus (HAV)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine class)

  1. GlaxoSmithKline · 19 drugs in this class
  2. Merck Sharp & Dohme LLC · 11 drugs in this class
  3. Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
  4. PATH · 5 drugs in this class
  5. Sanofi · 5 drugs in this class
  6. Bandim Health Project · 5 drugs in this class
  7. Centers for Disease Control and Prevention · 3 drugs in this class
  8. International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
  9. Beijing Center for Disease Control and Prevention · 2 drugs in this class
  10. Aga Khan University · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Attenuated Hepatitis A Vaccine, H2 Strain — Competitive Intelligence Brief. https://druglandscape.com/ci/attenuated-hepatitis-a-vaccine-h2-strain. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: